Read + Share
Bain SC, Min T. A new class of glucose-lowering therapy for type 2 diabetes: the latest
development in the incretin arena. Lancet 2023 Jun 26:S0140-6736(23)01182-0. doi: 10.1016/S0140-6736(23)01182.
PMID: 37385276
|
 |
|
Bain SC, Min T. A new class of glucose-lowering therapy for type 2 diabetes: the latest
development in the incretin arena. Lancet 2023 Jun 26:S0140-6736(23)01182-0. doi: 10.1016/S0140-6736(23)01182.
PMID: 37385276
|
|
|
|